| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
RVTY
Revvity
|
Jun 18, 2026 | BUY |
Buy
+5.2% avg upside
23 analysts
|
$120.00
20.06% Upside
|
+0.0% |
|
TEM
Tempus AI, Inc. Class A
|
Jun 01, 2026 | BUY |
Strong Buy
+33.4% avg upside
19 analysts
|
$68.00
33.67% Upside
|
-4.2% |
|
GRAL
GRAIL Inc
|
May 27, 2026 | BUY |
Buy
+2.9% avg upside
8 analysts
|
— | -18.4% |
|
A
Agilent
|
May 27, 2026 | BUY |
Strong Buy
+3.8% avg upside
32 analysts
|
$155.00
22.02% Upside
|
+7.3% |
|
TMO
Thermo Fisher
|
May 20, 2026 | BUY |
Strong Buy
+26.8% avg upside
38 analysts
|
— | +2.3% |
|
MDXH
MDxHealth
|
May 14, 2026 | BUY |
Strong Buy
+1070.8% avg upside
8 analysts
|
$1.50
176.33% Upside
|
-44.9% |
|
ALMR
Alamar Biosciences, Inc.
|
May 12, 2026 | BUY |
Strong Buy
+36.6% avg upside
5 analysts
|
$30.00
36.64% Upside
|
· |
|
XGN
Exagen
|
May 11, 2026 | BUY |
Strong Buy
+159.4% avg upside
10 analysts
|
$8.00
76.22% Upside
|
-8.5% |
|
CAI
Caris Life Sciences, Inc.
|
May 08, 2026 | BUY |
Strong Buy
+54.5% avg upside
20 analysts
|
$31.00
67.74% Upside
|
+2.1% |
|
PSNL
Personalis
|
May 08, 2026 | BUY |
Strong Buy
+12.8% avg upside
11 analysts
|
$10.00
5.17% Downside
|
+76.2% |
|
GH
Guardant Health
|
May 08, 2026 | BUY |
Strong Buy
-5.9% avg upside
30 analysts
|
$127.00
3.72% Downside
|
+34.9% |
|
PACB
Pacific Biosciences
|
May 08, 2026 | BUY |
Buy
+213.7% avg upside
14 analysts
|
$3.00
114.27% Upside
|
-20.6% |
|
QGEN
Qiagen
|
May 07, 2026 | HOLD |
Buy
+14.2% avg upside
23 analysts
|
$40.00
8.30% Upside
|
-2.2% |
|
TXG
10x Genomics
|
May 07, 2026 | HOLD |
Buy
-27.9% avg upside
18 analysts
|
$25.00
28.03% Downside
|
+41.6% |
|
NTRA
Natera
|
May 07, 2026 | BUY |
Strong Buy
+7.4% avg upside
26 analysts
|
$280.00
21.07% Upside
|
+3.0% |
|
QTRX
Quanterix
|
May 06, 2026 | HOLD |
Buy
+460.5% avg upside
8 analysts
|
$4.00
17.92% Upside
|
-23.4% |
|
WAT
Waters
|
May 06, 2026 | HOLD |
Buy
+3.6% avg upside
30 analysts
|
$385.00
8.32% Upside
|
+2.1% |
|
SERA
Sera Prognostics
|
May 06, 2026 | BUY |
Strong Buy
+325.6% avg upside
7 analysts
|
— | -3.3% |
|
ADPT
Adaptive Biotechnologies
|
May 06, 2026 | BUY |
Strong Buy
+19.9% avg upside
14 analysts
|
$21.00
19.88% Upside
|
+22.0% |
|
WGS
GeneDx Holdings
|
May 05, 2026 | BUY |
Strong Buy
+35.7% avg upside
9 analysts
|
$55.00
6.89% Downside
|
+77.7% |
|
BDSX
Biodesix
|
May 05, 2026 | BUY |
Strong Buy
+92.3% avg upside
8 analysts
|
$30.00
78.38% Upside
|
-0.9% |
|
SOPH
SOPHiA GENETICS
|
May 05, 2026 | BUY |
Strong Buy
+75.8% avg upside
7 analysts
|
— | -6.5% |
|
ILMN
Illumina
|
Apr 30, 2026 | HOLD |
Buy
-10.1% avg upside
30 analysts
|
$140.00
13.64% Downside
|
+25.5% |
|
AVTR
Avantor
|
Apr 29, 2026 | HOLD |
Buy
+49.6% avg upside
26 analysts
|
$9.00
6.02% Downside
|
+20.5% |
|
NAUT
Nautilus Biotechnolgy
|
Apr 28, 2026 | BUY |
Strong Buy
+404.4% avg upside
5 analysts
|
— | -7.7% |
|
NEO
NeoGenomics
|
Apr 28, 2026 | BUY |
Strong Buy
+37.2% avg upside
17 analysts
|
$14.00
25.87% Upside
|
+23.6% |
|
DHR
Danaher
|
Apr 21, 2026 | BUY |
Strong Buy
+21.9% avg upside
45 analysts
|
$240.00
35.56% Upside
|
-8.6% |
|
SEER
Seer
|
Feb 26, 2026 | BUY |
Strong Buy
+551.3% avg upside
5 analysts
|
— | -17.3% |
|
MYGN
Myriad Genetics
|
Feb 23, 2026 | HOLD |
Hold
+313.3% avg upside
24 analysts
|
$7.00
54.16% Upside
|
-10.7% |
|
BRKR
Bruker
|
Feb 13, 2026 | HOLD |
Buy
-7.0% avg upside
22 analysts
|
$43.00
24.93% Downside
|
+50.1% |
|
BDX
Becton Dickinson
|
Jul 14, 2025 | HOLD |
Buy
+35.5% avg upside
25 analysts
|
$183.00
27.13% Upside
|
+6.0% |
|
LAB
Standard BioTools
|
May 06, 2025 | BUY |
Buy
+645.3% avg upside
8 analysts
|
$2.50
201.32% Upside
|
-8.5% |
|
LULU
Lululemon Athletica
|
Apr 27, 2023 | BUY |
Buy
+90.2% avg upside
45 analysts
|
$525.00
369.73% Upside
|
-3.5% |
|
VZ
Verizon
|
Apr 26, 2023 | BUY |
Strong Buy
+11.3% avg upside
39 analysts
|
$45.00
0.87% Downside
|
+15.5% |
|
MRVI
Maravai Lifesciences Holdings
|
Oct 15, 2021 | BUY |
Strong Buy
+174.4% avg upside
17 analysts
|
$62.00
1092.38% Upside
|
-48.0% |
|
TWST
Twist Bioscience
|
Oct 14, 2021 | BUY |
Strong Buy
-26.4% avg upside
14 analysts
|
— | -75.0% |
|
CRL
Charles River Labs
|
Aug 17, 2021 | BUY |
Strong Buy
+11.9% avg upside
34 analysts
|
$465.00
151.39% Upside
|
-47.3% |
|
MTD
Mettler-Toledo
|
May 07, 2021 | SELL |
Buy
+2.7% avg upside
18 analysts
|
$1139.00
0.54% Downside
|
-2.9% |
|
IQV
IQVIA Holdings
|
Apr 23, 2021 | BUY |
Strong Buy
+34.5% avg upside
38 analysts
|
$275.00
63.98% Upside
|
-1.8% |
|
ICLR
Icon
|
Mar 01, 2021 | BUY |
Strong Buy
+23.8% avg upside
25 analysts
|
$232.00
59.00% Upside
|
+33.7% |
|
VCYT
Veracyte
|
Nov 26, 2013 | BUY |
Strong Buy
-20.7% avg upside
17 analysts
|
$16.00
70.22% Downside
|
-48.4% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.